# Relative Bioavailability Study for GSK1278863A

> **NCT01319006** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 30 (actual)

## Conditions studied

- Anaemia

## Interventions

- **DRUG:** GSK1278863A
- **DRUG:** GSK1278863A
- **DRUG:** GSK1278863A

## Key facts

- **NCT ID:** NCT01319006
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-25
- **Primary completion:** 2011-04-18
- **Final completion:** 2011-04-18
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319006, "Relative Bioavailability Study for GSK1278863A". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01319006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*